# Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma

> **NCT02095990** · PHASE3 · COMPLETED · sponsor: **Mesoestetic Pharma Group S.L.** · enrollment: 17 (actual)

## Conditions studied

- Facial Melasma

## Interventions

- **DRUG:** Hydroquinone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02095990
- **Lead sponsor:** Mesoestetic Pharma Group S.L.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03
- **Primary completion:** 2014-08
- **Final completion:** 2014-08
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2019-09-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02095990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02095990, "Efficacy and Safety of a 4% Hydroquinone Cream for the Treatment of Melasma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT02095990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*